Xarelto Lawsuit Filed By Ohio Victim With GI Bleed

October 16, 2015 – – BloodThinnerHelp.com reports that a woman from Ohio who suffered gastrointestinal bleeding after taking Xarelto for atrial fibrillation joins several others filing lawsuits against the drug. She claims that it caused her internal bleeding as well as connected health issues within just two months of use. Her lawsuit was filed in the United States District Court for the Southern District of Ohio.

Xarelto is a drug thinner, but is alleged to be more dangerous than older types of drug thinners, because it has no antidote. When patients taking other blood thinners suffer injuries and are bleeding, physicians are able to administer vitamin K treatments which counteract the blood thinners, allowing the blood to clot. New-version blood thinners like Xarelto, however, do not respond to vitamin K.

Xarelto (also known as rivaroxaban), was FDA approved in 2011 as what was thought to be a revolutionary new substitute for Coumadin (warfarin). It was designed to help reduce the risk of blood clots for patients known to be at risk for pulmonary embolism, strokes, or deep vein thrombosis, and was also commonly used to treat atrial fibrillation. The drug’s sales quickly skyrocketed, reaching over $1 billion across America.

After many consumers began to use the new drug, lawsuits and injury allegations also began to appear, spurring the FDA to provide severe “black box” warnings about the product.

Presiding Judge Fallon will see the consolidated and centralized lawsuits, currently numbering around 2,000, and has now set bellwether trials which are anticipated to be reviewed by juries in the later half of 2017. The lawsuits filed are against manufacturers Johnson & Johnson and Bayer. According to documents, the first two of the four trials will be held on February 6th, 2017 and March 13, 2017. These will be seen in the Eastern District of Louisiana. Other trial locations will include Mississippi and Texas.

“The number of lawsuits associated with Xarelto use are expected to continue growing,” stated Xarelto attorney Marc Goldich. “We urge individuals who have suffered from health issues after using the drug to contact us, so that they are able to evaluate their cases and potentially seek compensation for their suffering.”

Those who are interested in exploring their rights concerning the Xarelto lawsuits, or have questions regarding the subject, please contact Marc Goldich, Esq. by calling 866-425-8902 at their convenience.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004741